Duvyzat (givinostat): a new hope for Duchenne muscular dystrophy patients.

Ann Med Surg (Lond) · 2025 · PMC12055071 · PMID 40337409

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Based on pre-specified multiplicity adjustment, patients treated with givinostat showed reduced worsening on NSAA when compared to placebo, which was nominally significant but not statistically significant.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.